FR-008I
| Code | Size | Price |
|---|
| TAR-T25439-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
FR-008I is an antibiotic.
CAS:
58591-23-4
Formula:
C59H86N2O18
Molecular Weight:
1111.333
Purity:
0.98
SMILES:
C[C@@H](C[C@H](C)[C@H]1OC(=O)CC(O)CCCC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC(=O)C[C@H](O)[C@H]([C@@H](O)C[C@@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C=CC=CC=CC=CC=C/C=C/C=C/[C@@H]1C)C(O)=O)[C@@H](O)CC(=O)c1ccc(N)cc1
References
1. Afghani E, Akshintala VS, Khashab MA, Law JK, Hutfless SM, Kim KJ, Lennon AM, Kalloo AN, Singh VK. 5-Fr vs. 3-Fr pancreatic stents for the prevention of post-ERCP pancreatitis in high-risk patients: a systematic review and network meta-analysis. Endoscopy. 2014 Jul;46(7):573-80. doi: 10.1055/s-0034-1365701. Epub 2014 May 15. Review. PubMed PMID: 24830399.
2. Macdonald GZ, Button DC, Drinkwater EJ, Behm DG. Foam rolling as a recovery tool after an intense bout of physical activity. Med Sci Sports Exerc. 2014 Jan;46(1):131-42. doi: 10.1249/MSS.0b013e3182a123db. PubMed PMID: 24343353.
3. Honda T, Fujimoto K, Miyao Y. Feasibility of virtual 3-Fr percutaneous coronary intervention using standard guiding catheters. Postepy Kardiol Interwencyjnej. 2014;10(4):231-7. doi: 10.5114/pwki.2014.46763. Epub 2014 Nov 17. PubMed PMID: 25489315; PubMed Central PMCID: PMC4252319.
4. Sage PT, Sharpe AH. In vitro assay to sensitively measure T(FR) suppressive capacity and T(FH) stimulation of B cell responses. Methods Mol Biol. 2015;1291:151-60. doi: 10.1007/978-1-4939-2498-1_13. PubMed PMID: 25836309.